Skip to main content
. Author manuscript; available in PMC: 2018 Mar 22.
Published in final edited form as: Radiother Oncol. 2015 Dec 29;118(1):105–111. doi: 10.1016/j.radonc.2015.12.015

Table 2.

Patient reported quality of life and urinary symptom scores before and after radiation therapy for prostate cancer.

Pre-RT
Mean ± SD
Post-RT
Mean ± SD
P§
N = 28*
QOL (SF-36) (possible 0–100)
 Physical function 70.9 ± 24.5 68.1 ± 23.3 .464
 Role limits physical 65.3 ± 26.9 55.7 ± 29.1 .146
 Role limits emotional 84.8 ±19.1 78.4 ± 27.6 .180
 Vitality 62.5 ± 22.4 51.3 ± 24.7 .005
 Emotional well being 76.3 ± 16.9 78.5 ± 18.5 .429
 Social functioning 86.7 ± 16.5 73.8 ± 23.8 .008
 Bodily pain 68.1 ± 24.0 73.8 ± 20.4 .117
 General health 64.8 ± 19.9 70.6 ± 22.3 .117
 PCS 65.3 ± 19.0 65.6 ± 20.4 .907
 MCS 77.1 ± 15.4 70.0 ± 20.3 .028
Urinary symptoms (IPSS) (possible 0–35 for total, 0–5 for each subset)
 IPSS total 12.9 ± 9.2 20.7 ± 7.0 .001
 Incomplete emptying 1.6 ± 1.6 2.5 ± 1.3 .040
 Frequency 2.3 ± 2.0 3.3 ± 1.5 .011
 Intermittency 1.5 ± 1.7 2.0 ± 1.5 .170
 Urgency 1.6 ± 1.8 3.4 ± 1.4 <.001
 Weak stream 2.0 ± 1.8 2.8 ± 1.5 .042
 Straining 0.8 ± 1.4 1.4 ± 1.2 .143
 Nocturia 1.8 ± 1.3 2.7 ± 1.4 <.001
 IPSS quality of life 1.8 ± 1.4 3.2 ± 1.3 <.001
*

Complete data were available for 27 participants. One patient failed to complete his end of treatment questionnaire.

§

A Bonferroni adjustment was performed due to the large number of variables tested. As 19 variables were tested, the P-value below which differences were considered statistically significant was 0.05 divided by 19, which is equal to 0.003. Bold type indicates a P-value <0.003. SD = standard deviation, QOL = quality of life, IPSS = International Prostate Symptom Score, PCS = Physical Component Score, MCS = Mental Component Score.